The global demand for urolithiasis management devices has seen a steady rise in the past few years owing to the increasing prevalence of kidney stones. A 2015 study by the National Kidney Foundation of the U.S. states that one in 10 people in the country has kidney stones and that more than a half a million people are admitted to emergency rooms for kidney stone management every year. Across the globe as well, factors such as obesity, rising geriatric population, which is highly susceptible to kidney stones owing to reduced renal function and diabetes, and change in lifestyles are contributing to increased prevalence of kidney stone formation.
Transparency Market Research estimates that the global urolithiasis management devices market will exhibit a healthy 4.5% CAGR over the period between 2016 and 2024 and rise to a valuation of US$1.78 bn by 2024.
Clinics and Ambulatory Surgical Centers to Remain Dominant End-use Segments
Of the key end-users of urolithiasis management devices, including hospitals, ambulatory surgery centers (ASCs), and clinics, the segment of clinics led the global market in terms of both revenue and volume in 2015. In terms of revenue, the segment accounted for over 55% in the said year. The leading position of the market segment can be attributed to factors such as the significant rise in the number of people opting for urolithiasis surgeries and advancements in treatment options that have reduced the time required for undertaking the procedures. Over the period between 2016 and 2024 as well, the segment is expected to hold a commanding position in the global market, retaining its status as the leading revenue generator.
The demand for urolithiasis management devices across ambulatory surgical centers is expected to exhibit a strong growth over the next few years, with the end-user segment emerging as one of the most promising investment grounds for the global urolithiasis management devices market. The segment is expected to exhibit strong growth owing to high demand for ambulatory surgical centers and preference for day care surgeries across developing as well as developed parts of the world. Applications of urolithiasis management devices across the hospitals end-use segment is expected to witness stagnant growth as clinics and ambulatory surgical settings become more preferred owing to the lower cost of treatment and the need to be hospitalized for shorter lengths of time.
Rising Geriatric Population in Asia Pacific to Stimulate Increased Adoption
North America held a dominant share of nearly 36% in the global urolithiasis management devices market in 2015. Factors such as the rising prevalence of kidney stone, rising geriatric population, and campaigns undertaken to raise awareness about the risks associated with kidney stones by government bodies are central to the growth of the market in the region. Additionally, the introduction of new and innovative urolithiasis management devices such as laser lithotripters and flexible ureterenoscopes have also aided the healthy growth of the North America urolithiasis management devices market. The presence of high disposable income groups across developed economies such as the U.S. and Canada in North America, with a high prevalence of lifestyle-induced diseases such as obesity and a large base of geriatric population have also influenced the increased adoption of urolithiasis management devices.
The urolithiasis management devices market in Asia Pacific is expected to exhibit an impressive CAGR of 4.6% over the period between 2016 and 2024. The mounting geriatric population in the region is the key factor driving the urolithiasis management devices market in the next few years. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific), is region is presently home to more than half of the world’s population of people aged over 60 years and the number is expected to rise to more than 2.45 bn by 2050. Owing to this, the regions is expected to lead to a substantial rise in demand for urolithiasis management devices in the next few years.
Some of the key vendors operating in the global urolithiasis management devices market are C. R. Bard, Inc., Allengers Medical Systems Ltd, Dornier Medtech GmbH, Boston Scientific Corporation, Cook Group, Inc., Electro Medical Systems S.A., DirexGroup, Olympus Corporation, Karl Storz, and Siemens Healthcare.
Urolithiasis is development of kidney stones in the urinary system. It includes nephrolithiasis (development of kidney stones), ureterolithiasis (stone formation in ureters), and cystolithiasis (stone formation in the bladder). Urolithiasis is a common condition that affects at least 10% of the global population. Urinary stones are generally distinguished based on the location and chemical composition. Based on chemical composition, these are categorized into calcium, uric acid, and oxalate stones.
Kidney stones can be managed through different methods. The natural method involves improving quality of life. Other methods include drug treatment and kidney stone management devices. Major factors driving the kidney stone management devices market are rising geriatric population, increasing awareness, advancements in technology of the devices due to various external factors such as entry of new market players, increasing investment, and government initiatives.
This report on the global urolithiasis management devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. A detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as increasing preference for efficacious products, product innovation, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global urolithiasis management devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, clinical trials, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global Urolithiasis Management Devices market.
The global urolithiasis management devices market has been segmented based on device type, end-user, and geography. Urolithiasis management devices are categorized into shockwave lithotripters and ureterorenoscopes. Shockwave Lithotripters include ultrasound lithotripters, pneumatic lithotripters, and laser lithotripters. Ureterorenoscopes include rigid, semi-rigid, and flexible ureterorenoscopes. Shock wave lithotripters accounts for the major share of the urolithiasis management devices market. Extracorporeal lithotripters dominate the market; however, the laser lithotripters and flexible ureterorenoscopes segments are expected to witness high compound annual growth rate during the forecast period.
The major distribution channels for usage of urolithiasis management devices products include hospitals, clinics, and ambulatory surgical centers. Ambulatory surgical centers are set to witness rapid growth due to the various benefits ranging from affordability to the ease of access and available advanced technologies. These benefits include easy shipping, huge discounts, and convenience of purchasing from any location.
Geographically, the Urolithiasis Management Devices market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. North America accounted for the largest share of the global urolithiasis management devices market. The market in Asia Pacific is anticipated to expand at the fastest growth rate from 2016 to 2024.
Key players in the urolithiasis management devices market are Allengers Medical Systems Ltd, C. R. Bard, Inc., Cook Group, Inc., Dornier Medtech GmbH, DirexGroup, Karl Storz, Boston Scientific Corporation, Olympus Corporation, Siemens Healthcare, and Electro Medical Systems S.A.
The urolithiasis management devices market has been segmented as follows:
- Global Urolithiasis Management Devices Market, by Device Type
- Shockwave Lithotripter
- Intracorporeal Lithotripters
- Ultrasound Lithotripter
- Pneumatic Lithotripter
- Laser Lithotripter
- Extracorporeal Lithotripter
- Intracorporeal Lithotripters
- Rigid Ureterorenoscopes
- Semi-rigid Ureterorenoscopes
- Flexible Ureterorenoscopes
- Shockwave Lithotripter
- Global Urolithiasis Management Devices Market, by End User
- Ambulatory Surgical Centers
- Global Urolithiasis Management Devices Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia and New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- North Africa
- Rest of Middle East & Africa
- North America